OVERVIEW

Long Term Use of Proton Pump Inhibitors...Is it Safe? is organized by PharmCon, Inc. and will be held from Jun 20, 2018 - Dec 21, 2020.

Credits: 1.25 Contact Hour(s)

Target Audience: Nurse, Pharmacist, Pharmacy Technician

Overview:
Over the last number of years and even most recently observational studies have surfaced examining the long term safety of proton pump inhibitors, most notably the prescription PPIs. Some of the long term effects that have been observed in these studies include dementia, fractures, kidney disease, nutrient malabsorption, infections and most recently death. Despite all of the data that has been published it is important to look more closely at these studies since they are only observational and not randomized controlled trials. Unfortunately this information is readily available to the public via the media and it continues to pose concerns for not only patients but clinicians as well. It is important for pharmacists to be educated on this topic so they can appropriately communicate with their patients and prescribers on this class of medication.

Objectives:
Nurse/Pharmacist
• Review the indication and safety profile of the currently FDA approved prescription proton pump inhibitors
• Identify the long term safety concerns of the class of PPIs including the mechanism of action
• Keeping in mind the features of observational studies, analyze the study data pertaining to PPIs
• Based on the conclusions of observational studies, communicate findings with patients and other clinicians

Pharmacy Technician
• Review the indications for the current FDA approved prescription and nonprescription proton pump inhibitors (PPIs)
• Recognize warnings associated with the use of PPIs that are listed in the product package inserts
• Distinguish between randomized controlled studies trials and observational studies

Additional details will be posted as soon as they are available.